BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 13, 2021
View Archived Issues
First clinical data presented for BNT-211 in patients with CLDN6-positive solid tumors
Read More
Phase I dose-escalation study tests combination immunotherapy with belapectin and pembrolizumab
Read More
Galectin-3 mediates the crosstalk between the WNT and STAT3 signaling pathways in gastric cancer
Read More
Ono Pharmaceutical, Vanderbilt University present KCNT1/KCNK2 blockers
Read More
ReViral synthesizes new benzodiazepine derivatives
Read More
New anti-HBV compounds identified at Sunshine Lake Pharma
Read More
Suzhou Raymon Pharmaceuticals discovers PI3K-alpha inhibitors
Read More
ShanghaiTech University, Fudan University patent new PROTACs
Read More
New Angex Pharmaceutical anticancer compounds show preclinical potential
Read More
Full-data analysis from 12-month treatment phase of ALTISSIMO study in wet AMD
Read More
Nephraegis Therapeutics to develop NPH-022 for the prevention and treatment of AKI
Read More
New phase II trial evaluates CBP-201 for moderate to severe persistent asthma
Read More
Mitsubishi Tanabe discontinues development of MT-5745 for ulcerative colitis
Read More
Inovio reports preclinical data on next-generation pan-COVID-19 vaccine candidate INO-4802
Read More
Mabwell initiates first-in-human study of 9MW-1411
Read More
China's NMPA issues clinical trial approval for JS-103 for gout
Read More
Preclinical characterization of novel 3CL(pro) inhibitors against COVID-19
Read More
Clene Nanomedicine presents preliminary phase II data for CNM-Au8 in ALS
Read More
HU-6 enters phase II development as potential treatment of NASH
Read More
OCS-02 shows safety and efficacy in phase II study in patients with acute anterior uveitis
Read More
Dosing begins in phase II trial of onapristone and anastrozole in endometrial cancer
Read More
Xilio presents preclinical data on tumor-selective anti-CTLA-4 antibody XTX-101
Read More
AzurRx reports phase II interim data on MS-1819 for severe exocrine pancreatic insufficiency
Read More
Engineering blood cells can treat brain diseases
Read More